A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg Plus 250mg Loading Regimen and 500mg
Status:
Completed
Trial end date:
2019-03-13
Target enrollment:
Participant gender:
Summary
This study will assess the relationship between fulvestrant dose and efficacy in
postmenopausal women with oestrogen receptor positive advanced breast cancer.